Cargando…

Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era

Acute promyelocytic leukemia (APL) is a unique leukemia that is characterized by the PML::RARA fusion. This fusion is often detected by conventional karyotype and fluorescence in situ hybridization (FISH); however, rare cases are cryptic and require molecular techniques to identify the PML::RARA fus...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlin, Kirill, Bryke, Christine, Dias, Ajoy, Michaels, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092513/
https://www.ncbi.nlm.nih.gov/pubmed/35572917
http://dx.doi.org/10.1016/j.lrr.2022.100320
_version_ 1784705155881500672
author Karlin, Kirill
Bryke, Christine
Dias, Ajoy
Michaels, Phillip
author_facet Karlin, Kirill
Bryke, Christine
Dias, Ajoy
Michaels, Phillip
author_sort Karlin, Kirill
collection PubMed
description Acute promyelocytic leukemia (APL) is a unique leukemia that is characterized by the PML::RARA fusion. This fusion is often detected by conventional karyotype and fluorescence in situ hybridization (FISH); however, rare cases are cryptic and require molecular techniques to identify the PML::RARA fusion. Furthermore, as the incidence of these cases is rare, analysis by a targeted next-generation sequencing (NGS) panel of myeloid associated genes has never been reported. Herein, a clinical APL case is reported where the PML::RARA fusion was detected only by reverse transcriptase-polymerase chain reaction (RT-PCR), thus underscoring the necessity of utilizing complementary techniques when suspicion for APL is present.
format Online
Article
Text
id pubmed-9092513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90925132022-05-12 Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era Karlin, Kirill Bryke, Christine Dias, Ajoy Michaels, Phillip Leuk Res Rep Article Acute promyelocytic leukemia (APL) is a unique leukemia that is characterized by the PML::RARA fusion. This fusion is often detected by conventional karyotype and fluorescence in situ hybridization (FISH); however, rare cases are cryptic and require molecular techniques to identify the PML::RARA fusion. Furthermore, as the incidence of these cases is rare, analysis by a targeted next-generation sequencing (NGS) panel of myeloid associated genes has never been reported. Herein, a clinical APL case is reported where the PML::RARA fusion was detected only by reverse transcriptase-polymerase chain reaction (RT-PCR), thus underscoring the necessity of utilizing complementary techniques when suspicion for APL is present. Elsevier 2022-05-04 /pmc/articles/PMC9092513/ /pubmed/35572917 http://dx.doi.org/10.1016/j.lrr.2022.100320 Text en © 2022 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Karlin, Kirill
Bryke, Christine
Dias, Ajoy
Michaels, Phillip
Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title_full Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title_fullStr Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title_full_unstemmed Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title_short Cytogenetically cryptic PML::RARA fusion in acute promyelocytic leukemia: Testing strategies in the modern era
title_sort cytogenetically cryptic pml::rara fusion in acute promyelocytic leukemia: testing strategies in the modern era
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092513/
https://www.ncbi.nlm.nih.gov/pubmed/35572917
http://dx.doi.org/10.1016/j.lrr.2022.100320
work_keys_str_mv AT karlinkirill cytogeneticallycrypticpmlrarafusioninacutepromyelocyticleukemiatestingstrategiesinthemodernera
AT brykechristine cytogeneticallycrypticpmlrarafusioninacutepromyelocyticleukemiatestingstrategiesinthemodernera
AT diasajoy cytogeneticallycrypticpmlrarafusioninacutepromyelocyticleukemiatestingstrategiesinthemodernera
AT michaelsphillip cytogeneticallycrypticpmlrarafusioninacutepromyelocyticleukemiatestingstrategiesinthemodernera